PDGFRα inhibition in soft-tissue sarcomas: Have we gotten it all wrong?
Sign Up to like & getrecommendations! Published in 2019 at "EBioMedicine"
DOI: 10.1016/j.ebiom.2019.01.062
Abstract: Soft-tissue sarcomas (STS) are a wide group of rare cancers of mesendothelial cells. Its inhibition might therefore also have indirect and enchymal origin. Treatment modalities include surgery, radiotherapy and chemotherapy,mostly depending on the stage of… read more here.
Keywords: trial; soft tissue; inhibition; tissue sarcomas ... See more keywords